作者
Mitsunori Shiroishi, Kouhei Tsumoto, Kimie Amano, Yasuo Shirakihara, Marco Colonna, Veronique M Braud, David SJ Allan, Azure Makadzange, Sarah Rowland-Jones, Benjamin Willcox, E Yvonne Jones, P Anton van Der Merwe, Izumi Kumagai, Katsumi Maenaka
发表日期
2003/7/22
期刊
Proceedings of the National Academy of Sciences
卷号
100
期号
15
页码范围
8856-8861
出版商
National Academy of Sciences
简介
Ig-like transcript 4 (ILT4) (also known as leukocyte Ig-like receptor 2, CD85d, and LILRB2) is a cell surface receptor expressed mainly on myelomonocytic cells, whereas ILT2 (also known as leukocyte Ig-like receptor 1, CD85j, and LILRB1) is expressed on a wider range of immune cells including subsets of natural killer and T cells. Both ILTs contain immunoreceptor tyrosine-based inhibitory receptor motifs in their cytoplasmic tails that inhibit cellular responses by recruiting phosphatases such as SHP-1 (Src homology 2 domain containing tyrosine phosphatase 1). Although these ILTs have been shown to recognize a broad range of classical and nonclassical human MHC class I molecules (MHCIs), their precise binding properties remain controversial. We have used surface plasmon resonance to analyze the interaction of soluble forms of ILT4 and ILT2 with several MHCIs. Although the range of affinities …
引用总数
20032004200520062007200820092010201120122013201420152016201720182019202020212022202320243123341463338283242293031412128223843402514
学术搜索中的文章